Thingking of the Administration of Standardization Technical Committee of Medical Device

Chinese Journal of Pharmacovigilance ›› 2010, Vol. 7 ›› Issue (4): 211-212.

Previous Articles Next Articles

Thingking of the Administration of Standardization Technical Committee of Medical Device

DONG Fang

Center for Drug Reevalution, SFDA, Beijing 100045, China

Received:2016-02-19 Revised:2016-02-19 Online:2010-04-08 Published:2016-02-19

Abstract

Abstract: This essay aims to orient the obligations of Standardization Technical Committee of Medical Device(STCMD), study the scientific management which can make the best used of its capability and control medical device.Through combine the practice with the internal characters of medical device, discuss the Methods and measures which manage the technical committee for standardization of medical device and provide guidance and reference for it.

Key words: medical device, Standardization Technical Committee of Medical Device(STCMD), obligation, management

CLC Number:

R955

DONG Fang. Thingking of the Administration of Standardization Technical Committee of Medical Device[J]. Chinese Journal of Pharmacovigilance, 2010, 7(4): 211-212.

[1]	MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin. Drug traceability coding system in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172.
[2]	SHEN Yanjie, WU Yiqing. Management of adverse events during clinical trials [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 982-986.
[3]	ZHANG Qi, CHEN Min, ZHANG Shiqing. Conditional approval of medical devices in the United States and enlightenment [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1007-1010.
[4]	YUAN Sisi, WANG Guangyan, LI Yifan, LI Ruilian, DU Boran, FENG Xin. Safety-related risk factors in clinical management of narcotics and psychotropic substances via failure mode and effect analysis [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1027-1030.
[5]	ZHU Yuanchao, ZHANG Yatong, HU Xin. Principles and measures of medication risk management in the elderly [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1031-1034.
[6]	SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian. Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
[7]	ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei. Discuss the safety management of medical toxic drugs in medical institutions [J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
[8]	ZHAO Yan, LIU Wenbo, ZHAO Yifei, LI Dong, ZHENG Lijia, SONG Yana, ZHAO Yujuan, DONG Fang. Applicability of patient registry research to regulation of medical devices [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 423-427.
[9]	DING Qian, LI Boyu, ZHANG Qingxia. Risks to storage of nitroglycerin after unsealing and ways of prevention [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 326-330.
[10]	ZHAO Yan, LI Dong, CHENG Yinjie, JIANG Bin, ZHAO Yifei, DONG Fang, YUAN Jing. Advances in studies on post-market safety data sources and signal detection for medical devices [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 236-240.
[11]	TIAN Chunhua, WU Guizhi. Implementation of periodic benefit risk evaluation reports in China [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1382-1384.
[12]	ZHAO Yan, LI Yao, SONG Ya’na, ZHENG Lijia, LI Dong, ZHAO Yifei, BIAN Rongrong, DONG Fang. Post-marketing active monitoring of medical devices under vigilance [J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1385-1390.
[13]	LIU Hongliang, WANG Qing, HOU Yongfang. Design and implementation of polypharmacy risk data management platform for common diseases of the elderly based on real world data [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1095-1098.
[14]	ZHONG Lumiao, DU Juan, DENG Hua, WANG Yafeng, QIU Ping, ZENG Linggui. Thoughts on design and quality management of active safety surveillance research of traditional Chinese medicine injections initiated by Marketing Authorization Holder [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 994-998.
[15]	ZHANG Qingxia, JIANG Yongxian, LI Gen, YAN Suying, WANG Yuqin. Analysis and prevention of medication errors related to stored pharmaceuticals in National Monitoring Network for Clinical Safety Medication [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1040-1044.

Thingking of the Administration of Standardization Technical Committee of Medical Device

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics